20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

What Is BioGenerator?

BioGenerator is an evergreen investor that creates, grows, and funds innovative companies and talented entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to enabling lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development.

BioGenerator is the investment arm of BioSTL

Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Adarza’s products and services utilize its proprietary Arrayed Imaging Reflectometry™ (“AIR”) detection platform that is capable of rapid identification and quantification and offers key performance benefits in multiplexing, sensitivity, speed, sample size, dynamic range, and ease of use while affording industry-leading low cost. The AIR platform addresses many commercial applications, including disease biomarkers, personalized medicine, drug and vaccine development, allergy, immunology, and infectious diseases research.

Our Companies

The BioGenerator portfolio is a compilation of companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

Our Companies

The BioGenerator portfolio includes companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

BioGenerator and Synchrony Bio lead initial financing for Readout, a Digital Health Startup06/13/2019

BioGenerator Company Adarza BioSystems Reaches Commercialization Stage, Launches ZIVA Platform05/02/2019

BioGenerator Company Canopy Biosciences Raises Series B Led By Ampersand, Acquires Zellkraftwerk04/30/2019

Backed by Atlas Venture, BioGenerator Company Indalo Therapeutics Begins Clinical Program04/18/2019

Job Opening (BioSTL) — Professional to Lead Advancement04/04/2019

BioGenerator Company Arch Oncology Closes $50M Series B to Develop Best in Class Anti-CD-47 Therapies03/25/2019

BioGenerator Company Benson Hill Biosystems Continues Rapid Growth by Acquiring Schillinger Genetics03/19/2019

Vaccine Breakthrough Published in Nature Communications Highlights Research of Startup VaxNewMo02/21/2019

See All News

What Others Are Saying

Joseph Monahan
Jon Root
Matt Crisp

Stay Updated

Stay up to date with the latest BioGenerator news and details.